IHS Chemical Week

Archives :: Regions :: Western Europe :: Switzerland

Displaying 441 - 460 of 582 stories.
November 19, 2009
 Clariant says it will cut 570 jobs, about 3% of its workforce, through plant closures in an effort to reduce costs. The restructuring will cost about SF150 million ($149...
November 4, 2009
Clariant reported third-quarter operating income before exceptional items down 40% to SF107 million ($103.7 million) on 19% lower sales at SF1.69 billion. Clariant's profit margin...
November 3, 2009
Dow Chemical says that Geoffery E. Merszei, executive v.p. and CFO, will move to a new role as president of Dow Europe, Middle East and Africa, while also serving as chairman of Dow...
October 29, 2009
Lonza plans to eliminate about 450 jobs, or 5% of its workforce, due to volatility in market and financial performance being below expectations as a result of order cancellation and...
October 27, 2009
Syngenta says its newly-established Syngenta Ventures corporate venture capital subsidiary, has made an equity investment in Metabolon (Durham, NC), a privately-held biotechnology...
October 23, 2009
Crop protection sales were 10% lower, to $1.6 billion, while seed sales increased 3%, to $406 million....
October 22, 2009
Lonza says it has signed an investment agreement, including a right of first refusal for the commercial production of products, with innovative biotechnology company Cilian...
October 20, 2009
Lonza says it has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of pharmaceutical contract manufacturing and...
October 16, 2009
Lonza says it has acquired the preclinical cell and molecular biology assets of Simbiosys Biowares India (Bangalore, India), a biology outsourcing company. In a separate move, Merck...
October 14, 2009
Solvias (Basel, Switzerland) and Evonik say they have renewed a license agreement for a range of vanadium-doped precious metal powder catalysts for the hydrogenation of nitro...
September 30, 2009
The cuts form part of a restructuring of the company's operations in Europe....
September 28, 2009
Lonza says pharmaceutical contract manufacturing and development services company Patheon (Toronto), and Lonza have agreed to extend the exclusivity and due diligence period until...
September 10, 2009
Clariant’s focus for the next few years will be on restructuring as well as cash preservation and generation to support profitability and expansion by 2011 and beyond, Hariolf...
September 3, 2009
Over 2000 climate scientists, experts and decision-makers established a Global Framework for Climate Services to strengthen production, availability, delivery and application of...
August 21, 2009
Lonza says it has submitted a non-binding proposal to acquire all of the outstanding restricted voting shares of leading pharmaceutical contract manufacturing and development services...
July 22, 2009
Lonza has recorded a 33% fall in first-half net profits on a comparable basis, to SF118 million ($110 million), compared to the year-ago period. Sales were down 9%, to SF1.32 billion...
Pages: « Previous  14 15 16 17 18 19 20 21 22 [23] 24 25 26 27 28 29 30 Next »

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa